| GTO ID | GTC1263 |
| Trial ID | NCT00406939 |
| Disease | Prostate Cancer |
| Altered gene | IL-12 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Adv-IL12 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Study of Adenoviral Vector Delivery of The IL-12 Gene in Men With Recurrence or Persistent Cancer of the Prostate After Primary Therapy With or Without Metastatic Disease (SPORE) |
| Year | 2006 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | #H-6836|P50CA058204 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||